Do prostate cancer patients want to choose their own radiation treatment?

Tol-Geerdink, Julia J. van; Stalmeier, Peep F. M.; Lin, Emile N.J.T. van; Schimmel, Erik C.; Huizenga, H.; Daal, W.A.J. van; Leer, Jan-Willem H.

doi:10.1016/j.ijrobp.2006.07.001

Cited by 40 publications

(34 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…[30][31][32][33][34][35][36][37][38][39][40][41][42][43] The DAs were delivered in 4 settings: hospitals (4 studies), physician's offices (1 study), patient education centers (4 studies), and nonmedical settings such as home or research office (4 studies). Participants were recruited from academic and community settings.…”

Section: Study Settings Recruitment and Participantsmentioning

confidence: 99%

“…The majority of the DAs were developed de novo; 2 trials used a DA developed by Holmes-Rovner et al 35,36 Kim et al used a DA produced by a pharmaceutical company. 37 Most DAs presented information in multiple formats, including written materials (8 trials) 30,31,[33][34][35][36][38][39][40] and multimedia presentations (8 trials), [35][36][37][38][40][41][42][43] and provided individualized information for patients based on their disease stage. Two trials tested interventions involving information exchange via in-person consultation with urologists and a multidisciplinary team.…”

Section: Types Of Das and Control Interventionsmentioning

confidence: 99%

“…38 van Tol-Geerdink et al tested a written DA within the context of an interview. 30,31,34 Treatment options discussed in the DAs varied. Six DAs discussed "watchful waiting," surgical options, and radiation therapy (external beam radiation or brachytherapy).…”

Section: Types Of Das and Control Interventionsmentioning

confidence: 99%

“…33,37,42,43 One trial discussed surgery and radiation therapy only, 32 and 3 DAs described radiation therapy only. 30,31,34,41 The interdisciplinary consulting service described by Schostak et al involved both a urologist and radiation oncologist who jointly recommended a preferred treatment. 32 DAs developed or used in the United States and Canada were more likely to include all treatment options compared with DAs used in Europe.…”

Section: Types Of Das and Control Interventionsmentioning

confidence: 99%

“…[38][39][40]43 Four studies incorporated the DA into the physician visit. [30][31][32][33][34] Only 1 study reported data concerning the length of 38 In general, participants found DAs to be helpful and were satisfied with the content. Brink et al 41 and Holmes-Rovner et al 36 reported data concerning the clarity and usefulness of the DAs themselves.…”

Section: How Acceptable and Feasible Is The Use Of Das In Practice?mentioning

confidence: 99%

See 4 more Smart Citations

Patient Decision Aids for Prostate Cancer Treatment: A Systematic Review of the Literature

Lin¹,

Aaronson²,

Knight³

et al. 2009

CA: A Cancer Journal for Clinicians

127

106

View full text Add to dashboard Cite

Treatment decision-making can be difficult and complex for patients with low-risk prostate cancer. To the authors' knowledge, there is no consensus regarding an optimal treatment strategy and the choice of therapy involves tradeoffs between differing harms and benefits that are sensitive to patient values. In such situations, patients are often asked to participate actively in the decision-making process, and high-quality decisions require a well-informed patient whose values and preferences have been taken into consideration. Prior studies have indicated that patients have poor knowledge and unrealistic expectations regarding treatment, and physician judgments concerning patient preferences are often inaccurate. Decision aids (DAs) have been developed to help inform patients with low-risk prostate cancer about treatment options and assist in the decision-making process; however, little is currently known regarding the effects of such programs in this population. Thirteen studies of DAs for patients with prostate cancer were reviewed and it was found that the use of DAs can improve knowledge, encourage more active patient involvement in decision-making, and decrease levels of anxiety and distress. The effect of DAs on treatment choice was less clear, although fewer patients chose surgery compared with historical controls, particularly in Europe. Further studies are needed to determine how best to implement DAs into practice, and whether they improve the consistency between patient preferences and treatment choice.

show abstract